Global Health Economics, Outcomes Research Director

• Lead launch readiness and post-launch updates and development of core HEOR/Access deliverables including systematic and targeted literature reviews, burden of illness studies, unmet medical needs, clinical and patient-relevant outcomes, clinical guidelines, comparative effectiveness including evidence synthesis (including indirect treatment comparisons and network meta-analyses), Cost-Effectiveness Analysis models, Budget Impact Analysis models, Global Value Dossiers, Payer/Product Value Propositions, Objection Handlers for Ipsen products.
• Lead EU HTA Regulation JCA planning and execution as applicable aligned with product assignments.
• Support Payer value evidence communication through presentation of abstract/posters of key work at clinical and HEOR conferences and manuscript publications.
• Contribute to development, updates and execution of cross-functional Integrated Evidence Generation Plans for Ipsen products working with cross-functional teams ensuring strategic alignment of planned and ongoing HEOR activities.
• Lead and inform RWE, health outcomes / Patient-reported outcomes strategy and execution supporting development of a compelling Value proposition for payers and other key stakeholders.
• Lead and inform pipeline target product and value profile and clinical development plans including payer-relevant endpoint in clinical trials.
• Support development of pricing policy and market access of the company products.
• Work collaboratively with local affiliates and global cross-functional team including but not limited to Global Medical Affairs, Global Regulatory Affairs, Clinical, Biostatistics, Public Affairs, Marketing etc.
• Stay abreast of the evolving payer/HTA landscape in terms of policies, guidelines and trends leveraging up-to-date knowledge in strategic HEOR planning.
• Provide training to local country colleagues on value evidence for local adaptation and use.

Requirements

• A post graduate degree in health economics or related quantitative discipline
• At least 8 years' relevant experience in the field of HEOR in pharma industry, consultancy, or Academia, in an international setting
• Experience working on international HTA submissions
• Strong scientific analysis, interpretative and writing skills
• Knowledge of international health care systems
• Expertise on HEOR from Oncology, Rare Disease and/or Neuroscience including evidence synthesis, cost-effectiveness and budget impact modeling, RWE methodologies for outcomes research and PROs
• Knowledge of trial design and understanding of key clinical, PRO and resource utilization endpoints

Core Competencies

Demonstrates expertise in Health Economics and Outcomes Research (HEOR) with a focus on evidence synthesis, cost-effectiveness modeling, and real-world evidence methodologies. Proven ability to lead cross-functional teams and communicate value propositions effectively to payers and stakeholders.

Highest-signal resume keywords

• Health Economics Expertise
• Cost-Effectiveness Analysis
• Real-World Evidence Methodologies
• International HTA Submissions
• Scientific Analysis and Writing Skills

ATS Optimization Keywords Hard Skills

• Evidence Synthesis
• Budget Impact Modeling
• Clinical Trial Design
• Patient-Reported Outcomes (PROs)
• Comparative Effectiveness
• Systematic Literature Reviews
• Burden of Illness Studies
• Value Proposition Development
• Integrated Evidence Generation Plans
• Payer Value Evidence Communication

Soft Skills

• Collaboration
• Strategic Alignment
• Training and Development
• Communication Skills

Certifications & Qualifications

• Post Graduate Degree in Health Economics or Related Discipline

Industry Keywords

• Pharmaceutical Industry
• Health Technology Assessment (HTA)
• Oncology
• Rare Disease
• Neuroscience
• Global Value Dossiers
• Payer/Product Value Propositions
• Health Care Systems
• Clinical Guidelines
• Market Access